Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Holding VRDN?
Track your performance easily

Viridian Therapeutics (VRDN) Income Statement

1,036 Followers

Viridian Therapeutics Income Statement

Last quarter (Q1 2024), Viridian Therapeutics's total revenue was $72.00K, an increase of Infinity% from the same quarter last year. In Q1, Viridian Therapeutics's net income was $-48.54M. See Viridian Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 288.00K$ 314.00K$ 1.77M$ 2.96M$ 1.05M$ 4.46M
Cost of Revenue
------
Gross Profit
$ 288.00K$ 314.00K----
Operating Expense
$ 238.16M$ 254.76M$ -136.08M$ -82.69M$ 41.57M$ 46.44M
Operating Income
$ -237.87M$ -254.45M$ -136.08M$ -82.69M$ -40.52M$ -41.98M
Net Non Operating Interest Income Expense
$ 19.75M$ 16.72M$ 4.43M$ 315.00K$ -335.00K$ 106.00K
Other Income Expense
$ -519.00K$ -519.00K$ -1.77M$ -2.96M$ -69.86M-
Pretax Income
$ -218.13M$ -237.73M$ -129.87M$ -79.41M$ -110.72M$ -41.87M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -218.13M$ -237.73M$ -129.87M$ -79.41M$ -110.72M$ -41.87M
Basic EPS
$ -4.49$ -5.31$ -4.05$ -6.66$ -31.13$ -20.10
Diluted EPS
$ -4.49$ -5.31$ -4.05$ -6.66$ -31.13$ -20.10
Basic Average Shares
$ 197.88M$ 44.76M$ 32.09M$ 11.92M$ 3.56M$ 2.09M
Diluted Average Shares
$ 197.88M$ 44.76M$ 32.09M$ 11.92M$ 3.56M$ 2.09M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 238.16M$ 254.76M$ -136.08M$ -82.69M$ 41.57M$ 46.44M
Net Income From Continuing And Discontinued Operation
$ -218.13M$ -237.73M$ -129.87M$ -79.41M$ -110.72M$ -41.87M
Normalized Income
$ -81.15M---$ -40.85M$ -41.87M
Interest Expense
----$ 508.00K$ 835.00K
EBIT
$ -215.82M$ -235.89M$ -130.37M$ -79.41M$ -110.21M$ -41.04M
EBITDA
$ -162.98M$ -235.37M$ -130.10M$ -78.24M$ -109.97M$ -40.75M
Currency in USD

Viridian Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis